ArticleAngiogenesis2026
PINCH proteins as dual-function nodes in vascular mural cell homeostasis: from cytoplasmic scaffolds to nuclear gatekeepers.
Article in Angiogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wang and colleagues recently reported that PINCH proteins maintain vascular mural cell homeostasis through integrated cytoplasmic signaling and nuclear transcriptional mechanisms, identifying PINCH1 as a direct transcriptional coregulator of genes involved in inflammation, differentiation, and neurovascular integrity. While their multi-omics approach provides compelling mechanistic insight, several critical questions remain that warrant further investigation. This commentary discusses four key areas for future exploration: (1) the regulation of PINCH nucleocytoplasmic shuttling by mechanical cues, which remains a testable hypothesis given the mechanosensitivity of related focal adhesion proteins; (2) the need to dissect the relative contributions of cytoplasmic versus nuclear PINCH functions using compartment-restricted mutants and inducible deletion systems, as constitutive knockout models limit interpretation; (3) the unresolved hierarchy between signaling dysregulation and transcriptional reprogramming, which currently reflects correlative rather than causal findings; and (4) the importance of functional validation in human cells and tissues to establish whether PINCH downregulation drives vascular pathology or represents a secondary event. Addressing these questions will be essential to fully understand PINCH biology and to assess its therapeutic potential in vascular diseases such as atherosclerosis and aortic aneurysm.
Indexed as
Identifiers
42070184What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.